GlassScriptPhysician profile
John M Vanderen
NPI 1811986094
$18,597.00
in general payments reported to CMS, 2019-2025
25 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,866 · 2020: $9,424 · 2021: $2,751 · 2022: $1,464 · 2023: $416 · 2024: $366 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,274.79 | 2020-2025 | Aveir, Ensite, Merlin@Home |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,847.57 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $700.20 | 2019-2025 | |
| Medtronic Vascular, INC. | $501.54 | 2019 | |
| Janssen Pharmaceuticals, INC | $207.44 | 2019-2022 | |
| Philips North America LLC | $171.83 | 2022-2024 | (9278) Bridge |
| Pfizer INC. | $137.33 | 2022-2025 | |
| Edwards Lifesciences Corporation | $135.55 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $129.94 | 2021-2022 | |
| Boston Scientific Corporation | $108.34 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $84.71 | 2019-2023 | Eliquis |
| Novo Nordisk INC | $44.59 | 2024-2025 | Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $34.20 | 2025 | |
| Inspire Medical Systems, INC. | $25.28 | 2025 | Inspire |
| Bardy Diagnostics, INC. | $25.00 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.92 | 2019-2021 | |
| Atricure, INC. | $24.58 | 2024 | |
| Cardiva Medical, INC. | $20.63 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $17.03 | 2021 | |
| Esperion Therapeutics, INC. | $16.74 | 2021 | |
| Preventice Services, LLC | $16.17 | 2021 | |
| Abiomed | $13.83 | 2020 | |
| Kestra Medical Technology Services, INC. | $13.37 | 2023 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.60 | 2021 | |
| Cvrx, INC. | $8.82 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vanderen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.